CARDIFF ONCOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.525 USD | -0.42% |
|
+1.72% | +139.19% |
| May. 02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
| May. 02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 4.480 | 5.910 | 5.850 |
| Spread/Res. | -20.98% | -40.10% | -39.49% |
| Spread/Supp. | +10.62% | +38.82% | +22.07% |
| Support | 3.200 | 2.550 | 2.900 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CRDF Stock
- Charts Cardiff Oncology, Inc.